RMC No. 25-2025: FDA Updates to VAT-Exempt Medicines for Diabetes, Hypertension, High Cholesterol, and Mental Illness

RMC No. 25-2025 confirms FDA updates to VAT-exempt medicines for diabetes, hypertension, high cholesterol, and mental illness under TRAIN and CREATE. Businesses selling, purchasing, distributing, or accounting for medicines covered by the FDAโ€™s updated VAT-exempt list must immediately review their product master files, invoicing settings, and VAT treatment because the VAT exemption takes effect upon […]

RMC No. 131-2024: Updated VAT-Exempt Medicine List for Cancer, Diabetes, and Mental Illness Products

RMC No. 131-2024 updates the VAT-exempt medicine list for cancer, diabetes, and mental illness products, with effectivity tied to FDA publication. Businesses selling, dispensing, importing, distributing, or accounting for qualified medicines must immediately check the latest FDA-published list of VAT-exempt medicines because the VAT exemption under the CREATE Act takes effect based on the FDAโ€™s […]

RMC No. 34-2024: FDA Updates to VAT-Exempt Medicines for Cancer, Hypertension, and Mental Illness Under TRAIN and CREATE

RMC No. 34-2024 confirms FDA updates to VAT-exempt medicines for cancer, hypertension, and mental illness, with effect from FDA publication. Businesses selling medicines for cancer, hypertension, and mental illness must immediately check the latest Food and Drug Administration updates to the VAT-exempt product list because VAT exemption takes effect on the date the FDA publishes […]

RMC No. 124-2022: VAT-Exempt Medicines Updated for Cancer, Tuberculosis, Mental Illness, Diabetes, and Hypertension Under CREATE

RMC No. 124-2022 updates VAT-exempt medicines under CREATE for cancer, tuberculosis, mental illness, diabetes, and hypertension based on FDA publication. Businesses selling, importing, prescribing, dispensing, accounting for, or claiming VAT treatment on covered medicines must check the updated VAT-exempt medicine list immediately because the exemption applies based on the date the Food and Drug Administration […]